Facilities

Our brand new state-of-the-art current Good Manufacturing Practice (cGMP) facilities follow international standards specific for the complex manufacturing process of advanced therapy medicinal products to ensure quality, safety, and efficacy.

Designed to be compliant with United States Food and Drug Administration (USFDA), European Medicines Agency (EMA), and Pharmaceutical Inspection Co-operation Scheme (PIC/S) for early phase clinical trial materials in the cell and gene therapy markets
~22,000 ft² manufacturing facilities with cleanrooms, quality control, process development and research labs
HK’s first Grade A and B clean spaces
HK’s first multi-products cGMP manufacturing facility
Capability to introduce DNA, RNA or protein into cells
Cryogenic storage
Robust quality management system
24-hour remote Environmental Monitoring System:

Entrance to our cGMP facilities

Grade B Cleanroom

Cryogenic Storage

Environmental Monitoring during Manufacturing process

Nucleofector

Operation in Biological Safety Cabinets
(BSCs)

Our cGMP Facilities